# CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab

> **NCT05564923** · — · UNKNOWN · sponsor: **Namik Kemal University** · enrollment: 100 (estimated)

## Conditions studied

- Nivolumab Related Toxicity

## Interventions

- **DRUG:** there is no intervention

## Key facts

- **NCT ID:** NCT05564923
- **Lead sponsor:** Namik Kemal University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-02
- **Primary completion:** 2023-06-17
- **Final completion:** 2023-08-17
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05564923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05564923, "CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05564923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*